Found: 24
Select item for more details and to access through your institution.
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28839-y
- By:
- Publication type:
- Article
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 8, p. 3231, doi. 10.1172/JCI67655
- By:
- Publication type:
- Article
MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 5, p. 2257, doi. 10.1172/JCI67816
- By:
- Publication type:
- Article
The role of nucleotide binding and hydrolysis in the function of the fission yeast cdc18+ gene...
- Published in:
- Genetics, 1999, v. 151, n. 4, p. 1445, doi. 10.1093/genetics/151.4.1445
- By:
- Publication type:
- Article
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28839-y
- By:
- Publication type:
- Article
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2133, doi. 10.1007/s11095-023-03596-9
- By:
- Publication type:
- Article
Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41994-0
- By:
- Publication type:
- Article
Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01241-z
- By:
- Publication type:
- Article
Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031635
- By:
- Publication type:
- Article
MERTK Is a Potential Therapeutic Target in Ewing Sarcoma.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2831, doi. 10.3390/cancers16162831
- By:
- Publication type:
- Article
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6142, doi. 10.3390/cancers14246142
- By:
- Publication type:
- Article
Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5639, doi. 10.3390/cancers13225639
- By:
- Publication type:
- Article
The Emerging Role of TYRO3 as a Therapeutic Target in Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 12, p. 474, doi. 10.3390/cancers10120474
- By:
- Publication type:
- Article
Targeting the TAM Receptors in Leukemia.
- Published in:
- Cancers, 2016, v. 8, n. 11, p. 101, doi. 10.3390/cancers8110101
- By:
- Publication type:
- Article
Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 468, doi. 10.1007/s10637-010-9572-6
- By:
- Publication type:
- Article
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165107
- By:
- Publication type:
- Article
Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-10
- By:
- Publication type:
- Article
Machine learning classifier approaches for predicting response to RTK-type-III inhibitors demonstrate high accuracy using transcriptomic signatures and ex vivo data.
- Published in:
- Bioinformatics Advances, 2023, v. 3, n. 1, p. 1, doi. 10.1093/bioadv/vbad034
- By:
- Publication type:
- Article
Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors.
- Published in:
- ChemMedChem, 2017, v. 12, n. 3, p. 207, doi. 10.1002/cmdc.201600589
- By:
- Publication type:
- Article
Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening.
- Published in:
- Advanced Materials, 2022, v. 34, n. 10, p. 1, doi. 10.1002/adma.202108084
- By:
- Publication type:
- Article
Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening.
- Published in:
- Advanced Materials, 2022, v. 34, n. 10, p. 1, doi. 10.1002/adma.202108084
- By:
- Publication type:
- Article
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer.
- Published in:
- Nature Reviews Cancer, 2014, v. 14, n. 12, p. 769, doi. 10.1038/nrc3847
- By:
- Publication type:
- Article
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39152-z
- By:
- Publication type:
- Article